胃泌素抑制肽(GIP)牛血清白蛋白偶联物
BSA Conjugated Gastric Inhibitory Polypeptide (GIP)
Incretin hormone; Glucose Dependent Insulinotropic Peptide
- 编号UCPA882Mu11
 - 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
 - 来源蛋白偶联
 - 原分子量-
 - 缓冲液成份磷酸盐缓冲液(pH7.4)
 - 性状冻干粉
 - 纯度> 90%
 - 等电点-
 - 
                    应用
                    Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,请参见活性蛋白。 - 下载 英文说明书 中文说明书
 - 规格 10µg50µg 200µg 1mg 5mg
 - 价格 ¥ 360 ¥ 900 ¥ 1800 ¥ 5400 ¥ 13500
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
化学式
                                
                            用法
Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
相关产品
| 编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) | 
| URPA882Mu02 | 胃泌素抑制肽(GIP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPA882Mu01 | 胃泌素抑制肽(GIP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UCPA882Mu11 | 胃泌素抑制肽(GIP)牛血清白蛋白偶联物 | Immunogen; SDS-PAGE; WB. | 
| UCPA882Mu21 | 胃泌素抑制肽(GIP)卵白蛋白偶联物 | Immunogen; SDS-PAGE; WB. | 
| UPAA882Mu02 | 胃泌素抑制肽(GIP)多克隆抗体 | WB; IHC; ICC; IP. | 
| UPAA882Mu08 | 胃泌素抑制肽(GIP)多克隆抗体 | Testing in progress | 
| UPAA882Mu01 | 胃泌素抑制肽(GIP)多克隆抗体 | WB; IHC; ICC; IP. | 
| UMEA882Mu | 胃泌素抑制肽(GIP)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| UCEA882Mu | 胃泌素抑制肽(GIP)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMA882Mu | 胃泌素抑制肽(GIP)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
| UKSA882Mu11 | 胃泌素抑制肽(GIP)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". | 
参考文献
| 杂志 | 参考文献 | 
| Scientific Reports | The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlyingsignaling mechanisms in a rat model of diabetes mellitus. [pubmed:27721485] | 
| Obesity surgery | The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471] | 
| Obesity Surgery | Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague … [Pubmed:29098544] | 
| BioMed Research International | Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity [] | 
| Diabetes Research and Clinical Practice | Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225] | 
| OBESITY SURGERY | The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411] | 
| FUTURE SCIENCE | Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693] | 
    留言咨询

                    
                    
                                    